Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven

Clinical trial NCT06030089 · COMPLETED

Trial details

NCT number: NCT06030089
Sponsor: Centre Hospitalier Universitaire de Nice
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2024-02-26
Primary completion: 2024-09-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.